Formulation and In Vitro Evaluation of Transdermal Patches of Melatonin

Drug Development and Industrial Pharmacy

Volumn 30, Issue 2, 2004, Pages 205-212

  Kanikkannan, N ^a,b   Andega, S ^a   Burton, S ^a   Babu, R J ^a   Singh, Mandip ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

^b Paddock Laboratories Inc   (United States)

Author keywords

Drug release; Melatonin; Patches; Penetration enhancers; Transdermal

Indexed keywords

2 PROPANOL; ACETONE; ALCOHOL; DECANOL; EUDRAGIT; EUDRAGIT E 100; FATTY ACID; FATTY ALCOHOL; LIMONENE; MELATONIN; MENTHOL; MYRISTIC ACID; NONANOIC ACID; OCTANOL; POLYMER; SUCCINIC ACID; TERPENE; UNDECANOIC ACID;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; IN VITRO STUDY; MALE; NONHUMAN; PATCH TEST; RAT; STEADY STATE;

ACRYLATES; ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FATTY ACIDS; FATTY ALCOHOLS; MALE; MELATONIN; PERMEABILITY; POLYMERS; RATS; SKIN ABSORPTION; SOLUBILITY; TERPENES;

EID: 1842484885     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120028716     Document Type: Article

References (31)

1. Petrie, K.; Conaglen, L.; Thompson, L.; Chamberlain, K. Effects of melatonin on jet lag after long haul flight. Br. Med. J. 1989, 298, 705-707.
2. Waldhauser, F.; Vierhapper, H.; Oirich, K. Abnormal circadian melatonin secretion in night shift workers. N. Engl. J. Med. 1989, 7, 441-446.
3. Gagnier, J.J. The therapeutic potential of melatonin in migraines and other headache types. Altern. Med. Rev. 2001, 6, 383-389.
4. Benes, L.; Claustrat, B.; Horriere, F.; Geoffriau, M.; Konsil, J.; Parrott, K.A.; Degrande, G.; McQuinn, R.L.; Ayres, J.W. Transmucosal, oral controlled-release and transdermal drug administration in human subjects: a crossover study with melatonin. J. Pharm. Sci. 1997, 86, 1115-1119.
5. Babu, R.J.; Kanikkannan, N.; Kikwai, L.; Ortega, C.; Andega, S.; Ball, K.; Yim, S.; Singh, M. The influence of various methods of cold storage of skin on the permeation of melatonin and nimesulide. J. Control. Release 2003, 86, 49-57.
6. Naik, A.; Kalia, Y.N.; Guy, R.H. Transdermal drug delivery: overcoming the skin's barrier function. Pharm. Sci. Technol. Today 2000, 3, 318-326.
7. Lee, B.; Parrott, K.A.; Ayres, J.W.; Sack, R.L. Preliminary evaluation of transdermal delivery of melatonin in human subjects. Res. Commun. Mol. Pathol. Pharmacol. 1994, 85, 337-346.
8. Roberts, W.J.; Sloan, K.B. Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyloxymethyl-5-FU prodrugs. J. Pharm. Sci. 2003, 92, 1028-1036.
9. Beall, H.D.; Sloan, K.B. Transdermal delivery of 5-fluorouracil (5-FU) by 1-alkylcarbonyl-5-FU prodrugs. Int. J. Pharm. 1996, 129, 203-210.
10. Sloan, K.B.; Getz, J.J.; Beall, H.D.; Prankerd, R.J. Transdermal delivery of 5-fluorouracil (5-FU) through hairless mouse skin by 1-alkylaminocarbonyl-5-FU prodrugs: physicochemical characterization of prodrugs and correlations with transdermal delivery. Int. J. Pharm. 1993, 93, 27-36.
11. Kandimalla, K.; Kanikkannan, N.; Andega, S.; Singh, M. Effect of fatty acids on the permeation of melatonin across rat and pig skin in-vitro and on the transepidermal water loss in rats in vivo. J. Pharm. Pharmacol. 1999, 51, 783-790.
12. Andega, S.; Kanikkannan, N.; Singh, M. Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J. Control. Release 2001, 77, 17-25.
13. Kanikkannan, N.; Singh, M. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int. J. Pharm. 2002, 248, 219-228.
14. Kikwai, L.; Kanikkannan, N.; Babu, R.J.; Singh, M. Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro. J. Control. Release 2002, 83, 307-311.
15. Oh, H.J.; Oh, Y.K.; Kim, C.K. Effects of vehicles and enhancers on transdermal delivery of melatonin. Int. J. Pharm. 2001, 212, 63-71.
16. Zhao, K.; Singh, J. Mechanism(s) of in vitro percutaneous absorption enhancement of tamoxifen by enhancers. J. Pharm. Sci. 2000, 89, 771-780.
17. Rohm Pharma Polymers-Pressure-Sensitive Adhesive Matrix Based on EUDRAGIT E 100 for Manufacturing of Transdermal Therapy Systems; Provisional Technical Data Sheet, 10/99.
18. Musolf, M.C. Pressure sensitive adhesives: Science and engineering. In Transdermal Controlled Systemic Medications; Chien, Y.W., Ed.; Marcel Dekker: New York, 1987; 93-112.
19. Hadgraft, J. Pharmaceutical aspects of transdermal nitroglycerin. Int. J. Pharm. 1996, 135, 1-11.
20. Sloan, K.B.; Beall, H.D.; Taylor, H.E.; Getz, J.J.; Villaneuva, R.; Nipper, R.; Smith, K. Transdermal delivery of theophylline from alcohol vehicles. Int. J. Pharm. 1998, 171, 185-193.
21. Aungst, B.; Rogers, N.; Shefter, E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 1986, 33, 225-234.
22. Lee, C.; Uchida, T.; Noguchi, E.; Kim, N.; Goto, S. Skin permeation enhancement of Tegafur by ethanol/panasate 800 or ethanol/water binary vehicle and combined effect of fatty acids and fatty alcohols. J. Pharm. Sci. 1993, 82, 1155-1159.
23. Ogiso, T.; Koike, K.; Iwaki, M.; Tanino, T.; Tanabe, G.; Muraoka, O. Percutaneous penetration of ozagrel and the enhancement produced by saturated fatty acids. Biol. Pharm. Bull. 2000, 23, 844-849.
24. Golden, G.M.; Guzek, D.B.; Harris, R.R.; McKie, J.E.; Potts, R.O. Lipid thermotropic transitions in human stratum corneum. J. Invest. Dermatol. 1986, 86, 255-259.
25. Ogiso, T.; Shintani, M. Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propranolol. J. Pharm. Sci. 1990, 79, 1065-1071.
26. Barry, B.W.; Williams, A.C. Permeation enhancement through skin. In Encyclopedia of Pharmaceutical Technology; Swarbrick, J., Boylon, J.C., Eds.; Marcel Dekker: New York, 1995, Vol. 11, 449-493.
27. Williams, A.C.; Barry, B.W. Terpenes and the lipid-protein partitioning theory of skin penetration enhancement. Pharm. Res. 1991, 8, 17-21.
28. Kunta, J.R.; Goskonda, V.R.; Brotherton, H.O.; Khan, M.A.; Reddy, I.K. Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J. Pharm. Sci. 1997, 86, 1369-1373.
29. Lee, B.J.; Parrot, K.A.; Ayres, J.W.; Sack, R.L. Design and evaluation of an oral controlled release delivery system for melatonin in human subjects. Int. J. Pharm. 1995, 124, 119-127.
30. Lewy, A.J.; Newsome, D.A. Different types of melatonin circadian secretary rhythms in some blind subjects. J. Clin. Endocrinol. Metab. 1983, 56, 1103-1107.
31. Fourtillan, J.B.; Brisson, A.M.; Gobin, P.; Ingrand, I.; Decourt, J.P.; Girault, J. Bioavailability of melatonin in humans after day-time administration of D(7) melatonin. Biopharm. Drug Dispos. 2000, 21, 15-22.